158 related articles for article (PubMed ID: 20092963)
1. Impact of gastric filling on radiation dose delivered to gastroesophageal junction tumors.
Bouchard M; McAleer MF; Starkschall G
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):292-300. PubMed ID: 20092963
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study.
Zhang WZ; Chen JZ; Li DR; Chen ZJ; Guo H; Zhuang TT; Li DS; Zhou MZ; Chen CZ
World J Gastroenterol; 2014 Oct; 20(38):13973-80. PubMed ID: 25320535
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer dose escalation using a simultaneous integrated boost technique.
Welsh J; Palmer MB; Ajani JA; Liao Z; Swisher SG; Hofstetter WL; Allen PK; Settle SH; Gomez D; Likhacheva A; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):468-74. PubMed ID: 21123005
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
5. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
7. Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer.
Zhang T; Liang ZW; Han J; Bi JP; Yang ZY; Ma H
Radiat Oncol; 2015 May; 10():114. PubMed ID: 25986069
[TBL] [Abstract][Full Text] [Related]
8. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
Eccles CL; Bissonnette JP; Craig T; Taremi M; Wu X; Dawson LA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):582-8. PubMed ID: 18793961
[TBL] [Abstract][Full Text] [Related]
9. Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer.
Wu VW; Sham JS; Kwong DL
Br J Radiol; 2004 Jul; 77(919):568-72. PubMed ID: 15238403
[TBL] [Abstract][Full Text] [Related]
10. Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.
Wu AJ; Bosch WR; Chang DT; Hong TS; Jabbour SK; Kleinberg LR; Mamon HJ; Thomas CR; Goodman KA
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):911-20. PubMed ID: 26104943
[TBL] [Abstract][Full Text] [Related]
11. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.
Fakhrian K; Oechsner M; Kampfer S; Schuster T; Molls M; Geinitz H
Strahlenther Onkol; 2013 Apr; 189(4):293-300. PubMed ID: 23443611
[TBL] [Abstract][Full Text] [Related]
12. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
13. Escalation of radiotherapy dose in large locally advanced drug-resistant gastrointestinal stromal tumors by multi-shell simultaneous integrated boost intensity-modulated technique: a feasibility study.
Cui H; Li Y; Huang W; Lu W; Yi X
Radiat Oncol; 2022 Dec; 17(1):216. PubMed ID: 36578008
[TBL] [Abstract][Full Text] [Related]
14. Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans.
Siebers JV; Keall PJ; Wu Q; Williamson JF; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):422-33. PubMed ID: 16168835
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
Zhang F; Zheng M
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cerebral malignant gliomas.
Zheng R; Fan R; Wen H; Luo J; Yang Y
J BUON; 2015; 20(1):248-52. PubMed ID: 25778324
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
18. Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution.
Chen YJ; Liu A; Han C; Tsai PT; Schultheiss TE; Pezner RD; Vora N; Lim D; Shibata S; Kernstine KH; Wong JY
Med Dosim; 2007; 32(3):166-71. PubMed ID: 17707195
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer.
Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M
J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
